Charleen L. Hak

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

"SMAC"-down for the apoptosis-restoring drug, Xevinapant: What does its story reveal?

"SMAC"-down for the apoptosis-restoring drug, Xevinapant: What does its story reveal?

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 14, 2026

Xevinapant plus Chemoradiotherapy Negatively Sculpts the Tumor-Immune Microenvironment in Head and Neck Cancer.

Xevinapant plus Chemoradiotherapy Negatively Sculpts the Tumor-Immune Microenvironment in Head and Neck Cancer.

Journal: Cancer research communications

Published: October 02, 2025

Author Correction: Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion.

Author Correction: Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion.

Journal: Nature communications

Published: July 15, 2025

Interfaces Between the DNA Damage Response and Anti-cancer Immunity.

Interfaces Between the DNA Damage Response and Anti-cancer Immunity.

Journal: Cancer journal (Sudbury, Mass.)

Published: April 16, 2025

Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion.

Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion.

Journal: Nature communications

Published: March 18, 2024

The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse models.

The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse models.

Journal: Nature communications

Published: March 18, 2024

Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent adjuvant immunotherapy.

Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent adjuvant immunotherapy.

Journal: Nature communications

Published: January 05, 2024

Radiological Biomarkers in MRI directed Rectal Cancer Radiotherapy Volume Delineation.

Radiological Biomarkers in MRI directed Rectal Cancer Radiotherapy Volume Delineation.

Journal: Cancers

Published: September 05, 2023

The National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group Workshop: Translating Novel Discoveries to and from the Clinic.

The National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group Workshop: Translating Novel Discoveries to and from the Clinic.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: July 20, 2023

Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference.

Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference.

Journal: Oncoimmunology

Published: June 26, 2023

Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy.

Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy.

Journal: Frontiers in oncology

Published: June 17, 2022

Kickstarting Immunity in Cold Tumours: Localised Tumour Therapy Combinations With Immune Checkpoint Blockade.

Kickstarting Immunity in Cold Tumours: Localised Tumour Therapy Combinations With Immune Checkpoint Blockade.

Journal: Frontiers in immunology

Published: August 06, 2021

Showing 1-12 of 18

Last Updated: 09/26/2026